Devices·Jul 21, 2026
LLLT is the modality most likely to be dosed wrong in either direction — under-dosed for lack of confidence, over-dosed by assuming more is better. These are the working protocols we recommend and see reliably produce outcomes.
Dosing parameters
- Fluence: 0.5–8 J/cm² is the therapeutic window for most indications.
- Wavelength: 660 nm for skin/superficial; 810–850 nm for deeper; often both in the same session.
- Session length: 5–20 minutes per zone.
- Cadence: daily to weekly depending on indication.
Wound care
- Non-healing diabetic ulcer: 660 + 810 nm, 4 J/cm², over wound bed and 1 cm margin.
- 3× per week for the duration of active healing.
- Sequenced with standard wound care — LLLT does not replace debridement or off-loading.
Oral mucositis
- Intraoral 660 nm probe, 2–4 J/cm² per site over oral mucosa.
- Daily during chemo/radiation cycles; strongest evidence base of any LLLT indication.
Androgenic alopecia
- Cluster cap or scalp array at 655 nm, 5 J/cm² across the scalp.
- 3× per week ×6 months, then 2× per week maintenance.
- Combine with topical minoxidil, oral 5-α reductase inhibitor when indicated.
Temporomandibular joint dysfunction
- 810 nm, 6 J/cm², over TMJ capsule and masseter trigger points.
- 3× per week ×3 weeks, then 1× per week ×4.
Superficial neuropathies
Carpal tunnel syndrome
- 810 nm, 4 J/cm² over the carpal tunnel and proximal median nerve.
- 2× per week ×6 weeks; combine with night splinting.
Post-herpetic neuralgia (adjunct)
- 660 + 810 nm, 4 J/cm² over affected dermatome, daily to 3× per week.
Post-procedure recovery
Post-injection bruising and edema
- 660 nm, 2 J/cm² across affected area at 24 h and 72 h.
Post-CO₂ or fractional laser resurfacing
- 660 + 810 nm, 2–4 J/cm² over treated skin daily until re-epithelialization complete.
- Reduces recovery time by 20–40% in published studies.
Post-microneedling
- 660 nm, 2 J/cm² immediately post-procedure to reduce erythema and prime the wound-healing cascade.
Sports medicine and mild MSK
Lateral epicondylitis
- 810 nm, 6 J/cm², extensor origin and along common extensor tendon.
- 2× per week ×6 weeks combined with eccentric loading.
Minor sprains and strains
- 810 nm, 4 J/cm², daily for 5–7 days post-injury.
Head-to-head with related modalities
- vs HPLT: LLLT wins on cost, footprint, safety envelope, and thin tissue tolerance; HPLT wins on depth, speed, and deep-joint work.
- vs topical steroids: LLLT provides comparable inflammation reduction in oral mucositis and superficial dermatologic conditions without atrophy risk.
- vs therapeutic ultrasound: more mechanistically defined; comparable session length; different dose–response profile.
- vs at-home red-light panels: clinical LLLT devices have calibrated fluence and dose tracking; consumer panels typically do not — dose is unknown even when wavelength is correct.
Common protocol failures
- Treating for 30 seconds "to save time" — the effective dose is not reached.
- Using red 660 nm alone for deep MSK indications — insufficient penetration.
- Assuming more sessions per week is better — biology needs recovery time.
- Skipping baseline and outcome documentation, then losing the case narrative.